National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

Found 62,317 cases where Vaccine is DTAP

Government Disclaimer on use of this data



Case Details (Reverse Sorted by Appearance Date)

This is page 5 out of 3,116

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24   next


VAERS ID: 1916811 (history)  
Form: Version 2.0  
Age: 1.25  
Sex: Female  
Location: New Mexico  
Vaccinated:2021-11-29
Onset:2021-11-29
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-12-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (DAPTACEL) / SANOFI PASTEUR - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Crying, Injection site swelling, Lethargy, Peripheral swelling, Rash
SMQs:, Cardiac failure (broad), Anaphylactic reaction (broad), Angioedema (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Depression (excl suicide and self injury) (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: Every vaccine
Other Medications: No
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: Doctors keep turning me away.
CDC Split Type:

Write-up: Constant crying, her leg where vaccine was given tripled in size, whole body is covered in a rash, other limbs are swollen, and she is lethargic.


VAERS ID: 1915341 (history)  
Form: Version 2.0  
Age: 1.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-09-15
Onset:2021-09-15
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-12-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / OT
HIBV: HIB (ACTHIB) / SANOFI PASTEUR - / UNK - / OT
MMRV: MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) / MERCK & CO. INC. - / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Anaphylactic reaction, Breath sounds abnormal, Emotional distress, Erythema, Injection site erythema, Injection site reaction, Somnolence
SMQs:, Anaphylactic reaction (narrow), Anticholinergic syndrome (broad), Anaphylactic/anaphylactoid shock conditions (narrow), Dementia (broad), Acute central respiratory depression (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Extravasation events (injections, infusions and implants) (broad), Depression (excl suicide and self injury) (broad), Hypersensitivity (narrow), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: EPIPEN JR
Current Illness: Egg allergy
Preexisting Conditions: Medical History/Concurrent Conditions: Atopic eczema
Allergies:
Diagnostic Lab Data:
CDC Split Type: AUSA2021SA397558

Write-up: breath sounds abnormal; emotional distress; 9 x 10 cm erythema at right leg injection site MMRV(measles, mumps, rubella vaccine); somnolence; anaphylactic reaction; injection site reaction; Initial information was received on 18-Nov-2021 regarding an unsolicited valid serious case from a physician via regulatory agency (under reference AU-TGA-0000625357). This case involves a one-year-old female patient who experienced breath sounds abnormal, emotional distress, somnolence, anaphylactic reaction, 9 x 10 cm erythema at right leg injection site MMRV (measles, mumps, rubella vaccine) (erythema) and injection site reaction after receiving HIB (PRP/T) VACCINE [ACT-HIB], DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, TETANUS VACCINE TOXOID (INFANRIX) and MEASLES VACCINE LIVE (ENDERS-EDMONSTON), MUMPS VACCINE LIVE (JERYL LYNN), RUBELLA VACCINE LIVE (WISTAR RA 27/3), VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK) (PROQUAD). The patient''s medical history included Atopic eczema. At the time of the event, the patient had ongoing Egg allergy. Concomitant medications included EPINEPHRINE (EPIPEN JR). The patient''s past medical treatment(s), vaccination(s) and family history were not provided. On 15-Sep-2021, the patient received a dose of suspect HIB (PRP/T) VACCINE (Powder and solvent for solution for injection, lot number and expiry date not reported) via intramuscular route at an unknown administration site for prophylactic vaccination. On 15-Sep-2021, the patient received a dose of suspect INFANRIX not produced by Sanofi Pasteur (lot number and expiry date not reported) via intramuscular route at an unknown administration site for prophylactic vaccination. On 15-Sep-2021, the patient received a dose of suspect PROQUAD not produced by Sanofi Pasteur (lot number and expiry date not reported) via subcutaneous route at right leg site for prophylactic vaccination. On 15-Sep-2021, the patient developed a serious breath sounds abnormal, emotional distress, somnolence, anaphylactic reaction, 9 x 10 cm erythema at right leg injection site MMRV (measles, mumps, rubella vaccine) (erythema) and injection site reaction (on the same day) following the administration of HIB (PRP/T) VACCINE, INFANRIX and PROQUAD. These events were assessed as medically significant. Details of laboratory data not reported. On an unknown date, the patient received oral antihistamine as a corrective treatment for events. It was reported that then developed redness of face and later arms drowsiness distress noisy breathing clutching at leg. Ambulance called. At time of reporting, the outcome was unknown for all the event.; Sender''s Comments: This case concerns a one-year-old female who had breath sounds abnormality, emotional distress, somnolence, anaphylactic reaction, erythema and injection site reaction after receiving ACT-HIB, INFANRIX (unknown manufacturer) and PROQUAD (unknown manufacturer). The time to onset is compatible with the role of the vaccine. The patient''s medical history included Atopic eczema and egg allergy. Concomitant medications included EPINEPHRINE (EPIPEN JR). Furthermore, information regarding past medical treatment, vaccinations, condition at the time of vaccination and laboratory data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of individual vaccine cannot be assessed.


VAERS ID: 1912617 (history)  
Form: Version 2.0  
Age: 32.0  
Sex: Female  
Location: Georgia  
Vaccinated:2021-11-30
Onset:2021-11-30
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-12-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (DAPTACEL) / SANOFI PASTEUR - / 3 LA / SYR

Administered by: Private       Purchased by: ?
Symptoms: Dizziness, Extremity contracture, Muscle spasms, Muscular weakness, Paraesthesia, Syncope
SMQs:, Torsade de pointes/QT prolongation (broad), Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Dystonia (broad), Guillain-Barre syndrome (broad), Noninfectious encephalopathy/delirium (broad), Cardiomyopathy (broad), Vestibular disorders (broad), Hypotonic-hyporesponsive episode (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies: Asprin, muscle relaxers, cycline antibiotics
Diagnostic Lab Data: In progress.
CDC Split Type:

Write-up: Fainting, dizziness, tingling in fingers hands, lips, and toes, finger contractions, muscle spasms and weakness


VAERS ID: 1912808 (history)  
Form: Version 2.0  
Age: 5.0  
Sex: Male  
Location: Indiana  
Vaccinated:2021-11-24
Onset:2021-11-25
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-12-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (DAPTACEL) / SANOFI PASTEUR C5765BA / 5 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Injected limb mobility decreased, Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth, Product administered at inappropriate site
SMQs:, Drug abuse and dependence (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: None known
Current Illness: None known
Preexisting Conditions: Blood in stool, hx of blood in stool for years d/t constipation & straining. Recommended on date of vaccination to start using stool softeners.
Allergies: NKA
Diagnostic Lab Data: 11/26- pt went to urgent care for evaluation. mom reports they prescribed cefalexin for 5 days. 11/30, mom reported that the injection site has improved after course of cefalexin.
CDC Split Type:

Write-up: pt received dtap vaccine 11/24. mom texted 11/25 that the inj site was red and swollen (office closed for Thanksgiving). spoke with mom 11/26. 11/26, she reports redness & moderate swelling from the top of pt''s shoulder to nearly his elbow. reports it is hot to touch. denies fever, difficulty breathing, any other symptoms. mom reports pt occasionally acts like it''s itchy, but not frequently. doesn''t report pain (occasional regular soreness following vax). pt doesn''t act like it''s restricting his mobility. we were unable to see him in office 11/26, so recommended pt go to urgent care for evaluation.


VAERS ID: 1911597 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-11
Onset:2021-11-06
   Days after vaccination:240
Submitted: 0000-00-00
Entered: 2021-12-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (UNKNOWN)) / UNKNOWN MANUFACTURER - / 3 - / OT
DTAP: DTAP (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Blood test, Liver function test abnormal, SARS-CoV-2 test, White blood cell count
SMQs:, Liver related investigations, signs and symptoms (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: HYDROXYUREA
Current Illness: Polycythemia vera
Preexisting Conditions: Medical History/Concurrent Conditions: Neoplasm (Recently had treatment for cancer, leukaemia or lymphoma (radiotherapy or chemotherapy)); Comments: I take hydroxycarbamide chemo tablets nine a week and 75mg asprin Patient has not had symptoms associated with COVID-19
Allergies:
Diagnostic Lab Data: Test Name: blood test; Result Unstructured Data: low abnormal white blood count and abnormal liver function; Test Name: COVID-19 virus test; Test Result: Negative ; Test Name: white blood count; Result Unstructured Data: low abnormal
CDC Split Type: GBSA2021SA391126

Write-up: Abnormal liver function tests; Initial information was received on 24-Nov-2021 regarding an unsolicited valid serious case from a consumer or non-health care professional via Health Authority (under reference number: GB-MHRA-WEBCOVID-202111231007540770-KARJK). This case involves a 55-years-old female patient who had abnormal liver function tests (liver function test abnormal), after receiving DIPHTHERIA, TETANUS, AC PERTUSSIS AND IPV VACCINE and Coronavirus disease of 2019 (COVID-19) VACCINE MRNA (messenger Ribonucleic acid) (BIONTECH). Medical history included neoplasm with recently had treatment for cancer, leukaemia or lymphoma (radiotherapy or chemotherapy). Medical treatment included hydroxycarbamide chemo tablets nine a week and aspirine (aspirin) 75 mg. The patient have ongoing polycythemia vera. Patient''s family history were not provided. Concomitant medications included Hydroxyurea. The patient has not had symptoms associated with COVID-19. The patient was not enrolled in clinical trial. On an unknown date, the patient received a dose of suspect DIPHTHERIA, TETANUS, AC PERTUSSIS AND IPV VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via unknown route in unknown administration site for prophylactic vaccination. On 11-Mar-2021, the patient received a booster dose of suspect COVID-19 VACCINE MRNA not produced by Sanofi Pasteur (lot number and expiry date: not reported) via unknown route in unknown administration site for prophylactic vaccination. On 06-Nov-2021, the patient developed a serious abnormal liver function tests (liver function test abnormal) (unknown latency) following the administration of DIPHTHERIA, TETANUS, AC PERTUSSIS AND IPV VACCINE and 7 months 26 days following the administration of COVID-19 VACCINE MRNA. The event was assessed as medically significant. The patient felt shivering headache tired and ill within 12 hours of the vaccines. By day three she had routine blood test for her polycythemia vera and it came back with a low abnormal white blood count and abnormal liver function which has never happened before. She felt really ill for just over a week and she was starting to feel more normal at the time of this report, so hopefully when she gets the next blood test done a few weeks after the other one she was hoping it''s sorted itself out. Relevant laboratory test results included: severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] test - On an unknown date: Negative. It was not reported if the patient received a corrective treatment for the event. At the time of reporting, the outcome of the event was unknown. There will be no information available on the batch number for this case.; Sender''s Comments: This case involves a 55-years-old female patient who had abnormal liver function tests, after receiving DIPHTHERIA, TETANUS, AC PERTUSSIS AND IPV VACCINE (unknown manufacturer) and COVID-19 VACCINE MRNA BIONTECH (not produced by Sanofi Pasteur). The time to onset is unknown. Medical history included neoplasm. Concomitant medications included hydroxyurea. Blood test showed low abnormal white blood count and abnormal liver function which has never happened before. However, patient''s medical condition at time of vaccination and other etiologies would be needed for complete assessment of the case. Based upon the reported information, role the individual vaccine cannot be assessed.


VAERS ID: 1912053 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2015-10-14
Onset:2015-10-15
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-12-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (NO BRAND NAME) / UNKNOWN MANUFACTURER C475O / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Decreased appetite, Injection site reaction, Irritability, Oedema peripheral, Pain in extremity, Physical disability, Pruritus, Pyrexia, Tearfulness, Tenderness
SMQs:, Cardiac failure (broad), Anaphylactic reaction (broad), Angioedema (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Depression (excl suicide and self injury) (broad), Hypersensitivity (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: PLSA2021SA391889

Write-up: tenderness, pain in the entire upper limb; extensive limb oedema extending beyond two joints; The child was tearful, did not attend school, and had physical disabilities; erythema; The child was tearful, did not attend school, and had physical disabilities; swelling; itching; lack of appetite; The child was tearful, did not attend school, and had physical disabilities; irritability; fever; large reactions at the injection site (greater than 50mm); Initial information regarding this unsolicited valid serious case downloaded without narrative (level 2A), was received on 22-Nov-2021 from a Consumer/Non-HCP PL-URPL-P1222/2018. The following narrative is based on the information retrieved from all other accessible data. This case involves five-year-old male patient (116 cm and 20 kg) who experienced tenderness, pain in the entire upper limb (pain in extremity) large reactions at the injection site (greater than 50mm) (Injection site reaction), extensive limb oedema extending beyond two joints (Oedema peripheral), irritability, lack of appetite (Decreased appetite), the child was tearful, did not attend school, and had physical disabilities (School refusal), erythema, the child was tearful, did not attend school, and had physical disabilities (Psychomotor skills impaired), swelling, the child was tearful, did not attend school, and had physical disabilities (Tearfulness), fever (Pyrexia) and itching (Pruritus) after receiving DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [TRIPACEL]. The patient''s medical history, medical treatment(s), vaccination(s) and family history were not provided. On 14-Oct-2015, the patient received 0.5 ml dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [lot C475O and expiry date not reported] via intramuscular route at unknown administration site for prophylactic vaccination. On 15-Oct-2015 the patient developed serious tenderness, pain in the entire upper limb (pain in extremity) large reactions at the injection site (greater than 50mm) (Injection site reaction), extensive limb oedema extending beyond two joints (Oedema peripheral), irritability, lack of appetite (Decreased appetite), the child was tearful, did not attend school, and had physical disabilities (School refusal), erythema, the child was tearful, did not attend school, and had physical disabilities (Psychomotor skills impaired), swelling, the child was tearful, did not attend school, and had physical disabilities (Tearfulness), fever (Pyrexia) and itching (Pruritus) one day following the administration of DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE. These all events were assessed as medically significant. Other relevant laboratories details not reported. It was not reported if the patient received a corrective treatment for all the events. At time of reporting, the outcome was unknown for all the events.; Sender''s Comments: The time to onset is compatible with the role of the vaccine. However, information on medical history, condition at time of vaccination and lab tests ruling out alternate etiologies will be needed for further assessment.


VAERS ID: 1914009 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-16
Onset:2021-09-04
   Days after vaccination:19
Submitted: 0000-00-00
Entered: 2021-12-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / OT
HIBV: HIB (ACTHIB) / SANOFI PASTEUR - / UNK - / OT
MMR: MEASLES + MUMPS + RUBELLA (PRIORIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Contusion, Immune thrombocytopenia, Ocular hyperaemia, Oral mucosal blistering, Platelet count decreased
SMQs:, Severe cutaneous adverse reactions (broad), Anaphylactic reaction (broad), Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Systemic lupus erythematosus (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Accidents and injuries (narrow), Glaucoma (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Ear infection
Allergies:
Diagnostic Lab Data: Test Date: 20211105; Test Name: Platelet count decreased; Result Unstructured Data: Less than 10 (unit not reported).
CDC Split Type: AUSA2021SA393699

Write-up: This case involves a one-year-old female patient who experienced blisters inside mouth, blood streaks in eye and multiple bruises on body (immune thrombocytopenia) while receiving HIB (PRP/T) VACCINE [ACT-HIB], PRIORIX and INFANRIX. The patient''s past medical history included Ear infection (1 week prior). The patient''s past medical treatment(s), vaccination(s), concomitant medications, and family history were not provided. On 16-Aug-2021, the patient received a dose of suspect HIB (PRP/T) VACCINE (Powder and solvent for solution for injection)[lot number not reported and expiry date not provided] via unknown route in unknown administration site for prophylactic vaccination, a dose of suspect INFANRIX [lot number not reported and expiry date not provided] via unknown route in unknown administration site for prophylactic vaccination and a dose of suspect PRIORIX [lot number not reported and expiry date not provided] via unknown route in unknown administration site for prophylactic vaccination. On 04-Sep-2021 the patient developed blisters inside mouth, blood streaks in eye and multiple bruises on body (immune thrombocytopenia) 19 days following the administration of HIB (PRP/T) VACCINE, PRIORIX and INFANRIX. This event was assessed as medically significant. It is unknown if the patient experienced any additional symptoms/events. Relevant laboratory test results included: Development of ITP, Platelet count decreased - On 05-Nov-2021: [less than 10 (unit not reported)] It was not reported if the patient received a corrective treatment. At the time of report, the outcome of event was unknown. Reporter assessed the causal relationship with suspect vaccine as possible. There will be no information available on batch number for this case.; Sender''s Comments: This case involves a one-year-old female patient who experienced Immune thrombocytopenia after receiving ACT-HIB, PRIORIX and INFANRIX. Time to onset is compatible. Further information regarding concomitant medications, concurrent condition during vaccination, previous vaccination and tolerance are needed to fully assess this case. Based upon the reported information, the role of an individual suspect vaccine cannot be assessed.


VAERS ID: 1908310 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Massachusetts  
Vaccinated:2021-11-23
Onset:2021-11-23
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USGLAXOSMITHKLINEUS202124

Write-up: received infanrix instead of Boostrix; adult patient received Infanrix; This case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a adult patient who received DTPa (Infanrix) for prophylaxis. Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 23rd November 2021, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 23rd November 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The nurse practitioner reported that, an adult patient received Infanrix instead of Boostrix by mistake which led to wrong vaccine administered and inappropriate age at vaccine administration. The health care professional had not available patient demographics neither lot number and expiration date. The health care professional offered to collect the information and follow up with safety. The reporter consented to follow up.


VAERS ID: 1908314 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: North Carolina  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS 23T73 / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Product administered to patient of inappropriate age, Underdose
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USGLAXOSMITHKLINEUS202124

Write-up: been giving pediatric doses of this vaccine to adults; been giving pediatric doses of this vaccine to adults; This case was reported by a other health professional via call center representative and described the occurrence of underdose in an unspecified number of patients who received DTPa (Infanrix) (batch number 23T73, expiry date 30th April 2023) for prophylaxis. Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced underdose and inappropriate age at vaccine administration. On an unknown date, the outcome of the underdose and inappropriate age at vaccine administration were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at the vaccination was not applicable for this report. The reporter stated the number of patients were 58 as per his/her belief. No patient identifiers were reported. The reporter had one lot number to provide at this time, expiration date obtained from batch number identifier. The reporter stated that in a Chat with CCMA in reference to DTaP Infanrix, it came to his/her attention that out office had been giving pediatric doses of this vaccine to adults, which led to inappropriate age at vaccine administration and underdose. The reporter wanted to know how to report this and what was the recommendation to fix It. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up.


VAERS ID: 1908655 (history)  
Form: Version 2.0  
Age: 13.0  
Sex: Male  
Location: Kentucky  
Vaccinated:2021-11-15
Onset:2021-11-15
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (DAPTACEL) / SANOFI PASTEUR - / UNK - / -
HEP: HEP B (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / -
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR U6785AA / UNK RA / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Expired product administered
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USSA2021SA385850

Write-up: an expired dose was administered, no reported adverse event; Initial information was regarding an unsolicited valid non serious case was received from an other health professional via Agency (Reference number- 00858482) and transmitted to Sanofi on 15-Nov-2021. This case involves a 13-year-old male patient who received an expired dose MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (expired product administered). The patient''s medical history, past medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HEPATITIS B VACCINE and DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (DAPTACEL) for Immunisation. On 15-Nov-2021, the patient received a 0.5 mL dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (total, lot U6785AA, expiry date: 31-Oct-2021) via intramuscular route in the right deltoid for prophylactic vaccination. It was an actual medication error due to expired product administered (latency: same day). It was reported "caller would like information regarding re-vaccination." At time of reporting, no adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder''s compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.


VAERS ID: 1908670 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Texas  
Vaccinated:0000-00-00
Onset:2021-11-18
Submitted: 0000-00-00
Entered: 2021-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (DAPTACEL) / SANOFI PASTEUR - / UNK - / OT
DTAPIPV: DTAP + IPV (QUADRACEL) / SANOFI PASTEUR - / UNK - / OT
DTPPVHBHPB: DTAP+IPV+HIB+HEPB (VAXELIS) / MSP VACCINE COMPANY - / UNK - / OT
FLU4: INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) / SANOFI PASTEUR - / UNK - / OT
HIBV: HIB (ACTHIB) / SANOFI PASTEUR - / UNK - / OT
IPV: POLIO VIRUS, INACT. (IPOL) / SANOFI PASTEUR - / UNK - / OT
MNQ: MENINGOCOCCAL CONJUGATE (MENQUADFI) / SANOFI PASTEUR - / UNK - / OT
TD: TD ADSORBED (TENIVAC) / SANOFI PASTEUR - / UNK - / OT
TDAP: TDAP (ADACEL) / SANOFI PASTEUR - / UNK - / OT
UNK: VACCINE NOT SPECIFIED (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Medication error, Product storage error
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: TUBERSOL
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USSA2021SA392168

Write-up: Excursion occurred due to refrigerator door being left open total time out of range is 15 minutes and highest temperature recorded is 47.1 Fahrenheit with no AE; Initial information received on 18-Nov-2021 regarding an unsolicited non-valid non-serious case received from an other health professional. This case was invalid as unidentifiable patient involved. This case involves an unknown age and unknown gender patient for whom it was reported "excursion occurred due to refrigerator door being left open total time out of range is 15 minutes and highest temperature recorded is 47.1 fahrenheit for following vaccine VAXELIS, INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV], MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI], DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC], DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL], DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE [PENTACEL (VERO)], DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL], DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL], HIB (PRP/T) VACCINE [ACT-HIB] and IPV (VERO) [IPOL] and while treated with TUBERCULIN TEST [TUBERSOL]. The patient medical history, medical treatment(s), vaccination(s), concomitant medication, and family history were not provided. On an unknown date, the patient started taking TUBERSOL (TUBERCULIN TEST) Solution for injection dosage unknown (with an unknown batch number and expiry date) for Tuberculin test. On an unknown date, the patient received a dose of suspect HIB (PRP/T) VACCINE [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination. On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination. On an unknown date, the patient received a dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination. On an unknown date, the patient received a dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination. On an unknown date, the patient received a dose of suspect DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination. On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination. On an unknown date, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination. On an unknown date, the patient received a dose of suspect VAXELIS not produced by Sanofi Pasteur [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination. On an unknown date, the patient received a dose of suspect IPV (VERO) [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination. It was case of medication error due to product storage error on 18-NOV-2021 [Latency: on the same day]. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder''s compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. There will be no information available on the batch number for this case.


VAERS ID: 1908803 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Arkansas  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
DTAPHEPBIP: DTAP + HEPB + IPV (PEDIARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
DTAPIPV: DTAP + IPV (KINRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
HEP: HEP B (ENGERIX-B) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
TDAP: TDAP (BOOSTRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Product storage error
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USGLAXOSMITHKLINEUS202124

Write-up: inadvertently exposed to 55F / administered to patients.; This case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in an unspecified number of patients who received DTPa-IPV (Kinrix) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis, HAV (Havrix) for prophylaxis, hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis, HBV (Engerix B) for prophylaxis, hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa (Reduced antigen) (Boostrix) for prophylaxis, dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa (Infanrix) for prophylaxis, dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa-HBV-IPV (Pediarix) for prophylaxis and dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Kinrix, Kinrix Pre-Filled Syringe Device, Havrix, Havrix Pre-Filled Syringe Device, Engerix B, Engerix B Pre-Filled Syringe Device, Boostrix, Boostrix Pre-Filled Syringe Device, Infanrix, Infanrix Pre-Filled Syringe Device, Pediarix and Pediarix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Kinrix, Kinrix Pre-Filled Syringe Device, Havrix, Havrix Pre-Filled Syringe Device, Engerix B, Engerix B Pre-Filled Syringe Device, Boostrix, Boostrix Pre-Filled Syringe Device, Infanrix, Infanrix Pre-Filled Syringe Device, Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not applicable to this report The nurse stated that Kinrix, Havrix, Engerix-B, Boostrix, Pediarix, and Infanrix was inadvertently exposed to 55 degree Fahrenhiet for as long as two weeks which led to incorrect storage of drug. Worst case scenario, some of the vaccines were administered to patients. No further details available at the time of this call, but nurse granted permission for safety to follow up via mail. The reporter consented to follow up.


VAERS ID: 1906096 (history)  
Form: Version 2.0  
Age: 2.0  
Sex: Male  
Location: Oklahoma  
Vaccinated:2021-11-19
Onset:2021-11-20
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-11-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS 7EC55 / 4 RL / IM
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS YG7YJ / 1 LL / IM
HIBV: HIB (PEDVAXHIB) / MERCK & CO. INC. T026066 / 3 LL / IM
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. T029549 / 1 LL / SC
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH EJ4562 / 4 RL / IM
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. U008181 / 1 RL / SC

Administered by: Public       Purchased by: ?
Symptoms: Pyrexia, Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Cetirizine 5ml QD Hydrocortisone 2.5% cream
Current Illness: N/A
Preexisting Conditions: N/A
Allergies: N/A
Diagnostic Lab Data: Patient reported to Dr. for concerns over the possible reaction to vaccines. Advised parent that fever is normal for up to 3 days after vaccines. Although hives are an abnormal reaction, the closer the reaction of the disease (MMR) then the more prominent the coverage against the disease.
CDC Split Type:

Write-up: Breakout of hives all over affected area and tactile fever the next day.


VAERS ID: 1899221 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Florida  
Vaccinated:2021-11-11
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-11-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
FLU4: INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
HEP: HEP B (ENGERIX-B) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
TDAP: TDAP (BOOSTRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Product storage error
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USGLAXOSMITHKLINEUS202123

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis. Co-suspect products included HAV (Havrix) for prophylaxis, HBV (Engerix B) for prophylaxis, DTPa (Infanrix) for prophylaxis, dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis, Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2021-2022 season) for prophylaxis and flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 11th November 2021, the patient received Boostrix, Havrix, Engerix B, Infanrix, Infanrix Pre-Filled Syringe Device, Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device. On an unknown date, unknown after receiving Boostrix, Havrix, Engerix B, Infanrix, Infanrix Pre-Filled Syringe Device, Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The practice administrator reported temperature of 24.4 Fahrenheit, which patients having received the vaccinations after the temperature excursion, which led to incorrect storage of drug. The reporter consented to follow up.


VAERS ID: 1896297 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: New York  
Vaccinated:2021-10-27
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
DTAPHEPBIP: DTAP + HEPB + IPV (PEDIARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
DTAPIPV: DTAP + IPV (KINRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
FLU3: INFLUENZA (SEASONAL) (FLULAVAL) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
HEP: HEP B (ENGERIX-B) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK - / -
MNQ: MENINGOCOCCAL CONJUGATE (MENVEO) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK - / -
TDAP: TDAP (BOOSTRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Product storage error
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USGLAXOSMITHKLINEUS202123

Write-up: were exposed to 30.2F for about 1h; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received Flu Seasonal QIV Quebec (FluLaval Tetra 2021-2022 season) for prophylaxis. Co-suspect products included flu seasonal qiv quebec pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa (Infanrix) for prophylaxis, dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa (Reduced antigen) (Boostrix) for prophylaxis, Men ACWY-CRM NVS (Menveo) for prophylaxis, Men B NVS (Bexsero) for prophylaxis, meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis, HBV (Engerix B) for prophylaxis, hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis, HAV (Havrix) for prophylaxis, DTPa-HBV-IPV (Pediarix) for prophylaxis, dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa-IPV (Kinrix) for prophylaxis and dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 27th October 2021, the patient received FluLaval Tetra 2021-2022 season, Flulaval Tetra Pre-Filled Syringe Device, Infanrix, Infanrix Pre-Filled Syringe Device, Boostrix, Menveo, Bexsero, Bexsero Pre-Filled Syringe Device, Engerix B, Engerix B Pre-Filled Syringe Device, Havrix, Pediarix, Pediarix Pre-Filled Syringe Device, Kinrix and Kinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving FluLaval Tetra 2021-2022 season, Flulaval Tetra Pre-Filled Syringe Device, Infanrix, Infanrix Pre-Filled Syringe Device, Boostrix, Menveo, Bexsero, Bexsero Pre-Filled Syringe Device, Engerix B, Engerix B Pre-Filled Syringe Device, Havrix, Pediarix, Pediarix Pre-Filled Syringe Device, Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The medical assistant reported that, had a freezing temperature excursion that affected their vaccines. The vaccines were exposed to 30.2 Fahrenheit for about 1hour and the reporter did not know if the vaccines were administered after that excursion. The reporter consented to follow up.


VAERS ID: 1897709 (history)  
Form: Version 2.0  
Age: 5.0  
Sex: Male  
Location: Oklahoma  
Vaccinated:2021-11-19
Onset:2021-11-19
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS XG942 / N/A RA / IM
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS YG74J / 1 RA / IM
IPV: POLIO VIRUS, INACT. (IPOL) / SANOFI PASTEUR U1A452M / N/A RA / IM
MMRV: MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) / MERCK & CO. INC. U009259 / 2 RA / SC

Administered by: Public       Purchased by: ?
Symptoms: Extra dose administered
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: N/A
CDC Split Type:

Write-up: When adding vaccination history as provided by patient''s records, public health nurse misinterpreted "Refuerzo" as refused instead of the correct interpretation, reinforced (or additional). This resulted in a non-indicated, additional dose of DTap and IPV being administered to the patient.


VAERS ID: 1897808 (history)  
Form: Version 2.0  
Age: 1.75  
Sex: Female  
Location: California  
Vaccinated:2021-11-19
Onset:2021-11-19
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-11-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (DAPTACEL) / SANOFI PASTEUR C5828AA / 1 LL / IM

Administered by: Private       Purchased by: ?
Symptoms: Febrile convulsion
SMQs:, Convulsions (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Generalised convulsive seizures following immunisation (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: None known of.
Current Illness: None
Preexisting Conditions: None
Allergies: None known of
Diagnostic Lab Data: ED visit. No testing performed.
CDC Split Type:

Write-up: Febrile Seizure 12 hours after immunization


VAERS ID: 1892638 (history)  
Form: Version 2.0  
Age: 5.0  
Sex: Male  
Location: California  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-11-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
DTAPIPV: DTAP + IPV (KINRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Extra dose administered, Inappropriate schedule of product administration
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Kinrix Pre-Filled Syringe Device; Infanrix Pre-Filled Syringe Device
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USGLAXOSMITHKLINEUS2021AM

Write-up: was given a dose of Kinrix as well as Infanrix in the same visit; was given a dose of Kinrix as well as Infanrix in the same visit.; This case was reported by a nurse via sales rep and described the occurrence of overdose in a 5-year-old male patient who received DTPa-IPV (Kinrix) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa (Infanrix) for prophylaxis and dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Kinrix, Kinrix Pre-Filled Syringe Device, Infanrix and Infanrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Kinrix, Kinrix Pre-Filled Syringe Device, Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced overdose and inappropriate schedule of vaccine administered. On an unknown date, the outcome of the overdose and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were reported as follows: The case was reported by the patient. The patient was given both a single dose of Kinrix as well as Infanrix in the same visit, which led to overdose and inappropriate schedule of vaccine administered. Consent to follow up granted.


VAERS ID: 1892648 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: South Dakota  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-11-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (NO BRAND NAME) / UNKNOWN MANUFACTURER UNK / 5 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Incomplete course of vaccination
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USGLAXOSMITHKLINEUS202123

Write-up: 7 years 8 months received only 4 doses in the Dtap series.; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 7-year-old patient who received DTPa (DTaP vaccine) for prophylaxis. Previously administered products included Dtap (received 4 dose of Dtap). On an unknown date, the patient received the 5th dose of DTaP vaccine. On an unknown date, unknown after receiving DTaP vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown. Additional details were provided as follows: The age at vaccination was not applicable for this report. The patient 7 years 8 months received only 4 doses in the Dtap series. Till the time of reporting, the patient did not received 5th dose of Dtap, which led to incomplete course of vaccination. The reporter wanted to know how to proceed with Dtap series since patient was to old for the Infanrix and to young for the Boostrix. According to the CDC catch up series patient would be receiving the Boostrix as the 5th dose dose in the Dtap series. Patient had not received the Boostrix before the call was placed with Medical Information. The reporter did not consent to follow up.


VAERS ID: 1892658 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: New York  
Vaccinated:2021-09-01
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-11-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / SMITHKLINE BEECHAM - / UNK - / -
DTAPHEPBIP: DTAP + HEPB + IPV (PEDIARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
HEP: HEP B (ENGERIX-B) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
MNQ: MENINGOCOCCAL CONJUGATE (MENVEO) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK - / -
TDAP: TDAP (BOOSTRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Product storage error
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Engerix B Pre-Filled Syringe Device; Infanrix Pre-Filled Syringe Device; Pediarix Pre-Filled Syringe Device;
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USGLAXOSMITHKLINEUS202123

Write-up: vaccines were administered after temperature excursion; This case was reported by a physician via call center representative and described the occurrence of incorrect storage of drug in a patient who received HBV (Engerix B) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa (Infanrix) for prophylaxis, dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa (Reduced antigen) (Boostrix) for prophylaxis, HAV (Havrix) for prophylaxis, Men ACWY-CRM NVS (Menveo) for prophylaxis, DTPa-HBV-IPV (Pediarix) for prophylaxis and dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis. In September 2021, the patient received Engerix B, Engerix B Pre-Filled Syringe Device, Infanrix, Infanrix Pre-Filled Syringe Device, Boostrix, Havrix, Menveo, Pediarix and Pediarix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Engerix B, Engerix B Pre-Filled Syringe Device, Infanrix, Infanrix Pre-Filled Syringe Device, Boostrix, Havrix, Menveo, Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The physician reported that, had a freezing temperature excursion for their vaccines back in September 2021. These vaccines were administered after this excursion but they had no details at the moment about the patients or the vaccines. The reporter consented to follow up.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=5&PERPAGE=20&ESORT=ENTRY-DATE&REVERSESORT=ON&VAX=DTAP


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166